Low LDL from genetically reduced PCSK9 function lowers CV mortality but not all cause mortality. Over 1million person years data so it should be adequately powered. Maybe we need to LDL for something else?@DaveKeto https://t.co/fyj68gE80X
RT @doctorheart00: Pacientes con hipercolesterolemia Genética les reduce el riesgo cardiovascular con inhibidores PSCK9 pero ! Necesitamos…
RT @doctorheart00: Pacientes con hipercolesterolemia Genética les reduce el riesgo cardiovascular con inhibidores PSCK9 pero ! Necesitamos…
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
RT @doctorheart00: Pacientes con hipercolesterolemia Genética les reduce el riesgo cardiovascular con inhibidores PSCK9 pero ! Necesitamos…
Mira Augusto @alavallecobo LDL bajo por variante genética de PCSK9 Mucha menos mortalidad CV, pero igual mortalidad global Coincidente con FOURIER ODYSSEY, tal vez manejo mejor infecciones¿? Pero, ¿Estamos jugando con fuego? https://t.co/j81g0S2XGx http
Pacientes con hipercolesterolemia Genética les reduce el riesgo cardiovascular con inhibidores PSCK9 pero ! Necesitamos ver estudios comparativos en prevención primaria para proponer los @EstebanDL @Risantilopezcar @SIAC_cardio
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
Genetically low LDL cholesterol due to PCSK9 variation was causally associated with low risk of cardiovascular mortality in a cohort of >100 thousand individuals in Copenhagen. https://t.co/AbkCWHXIkd Via @JACCJournals https://t.co/kGCPS7BJo3
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? http…
Genetically low LDL due to #PCSK9 inhibition results in lower CVD risk. Is it time to use PCSK9 for primary #cvPrev? https://t.co/XgGNdafPBT #JACC @uni_copenhagen @Rigshospitalet https://t.co/hXGGrP1IlO
Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular Mortality https://t.co/jxl28i5lh8
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition leads to lower #CVD risk, but not low all-cause mortality. https://t.co/HEDO…
@DrNadolsky It's based on composite endpoints of "Major vascular events", I'm not a huge fan. This one which reports ACM https://t.co/FmGTuCGa7Z was not significant.
RT @JACCJournals: Genetically low LDL due to #PCSK9 inhibition leads to lower #CVD risk, but not low all-cause mortality. https://t.co/HEDO…
Genetically low LDL due to #PCSK9 inhibition leads to lower #CVD risk, but not low all-cause mortality. https://t.co/HEDOFN2L4r #JACC @uni_copenhagen @Rigshospitalet https://t.co/Q6hW0aGrYg
RT @pnatarajanmd: Missense genetic variants in PCSK9 that lower LDL-C also lower cardiovascular mortality risk https://t.co/i6gdVyIcMP @JAC…
Good paper for the DENIERS to read
Estudio testea si las personas con bajo LDL de nacimiento por disminución de PCSK9, se mueren menos. Si... se mueren menos de enf cardiovascular, pero la mortalidad global es igual https://t.co/HXT55A0AAa Justo lo contrario que dieron los medicamentos que
RT @ArsenaultBenoit: Loss of function in PCSK9 variation reduces cardiovascular mortality in the Cophengagen studies. CV mortality effet se…
RT @pnatarajanmd: Missense genetic variants in PCSK9 that lower LDL-C also lower cardiovascular mortality risk https://t.co/i6gdVyIcMP @JAC…
Missense genetic variants in PCSK9 that lower LDL-C also lower cardiovascular mortality risk https://t.co/i6gdVyIcMP @JACCJournals https://t.co/VUxDdEsnYh